A couple of years ago, I received a call from an investment banker and was advised to buy VirnetX (NYSEMKT:VHC) when it was trading at $2 a share. I looked at the company and hated it. There was no way I was going to buy this upstart that was suing Microsoft. What chance would they have? At that time, patent litigation was virtually unknown by Wall Street. VirnetX shares dropped to $1. I felt vindicated. VirnetX was a dog!
But to my surprise, VirnetX prevailed over Microsoft and was awarded a $200 million settlement. I became a convert. I bought shares at $5. The shares rose to $40. Over a two-year period, I traded VirnetX on a regular...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|